Received Mar 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLUN4 | INFLUENZA (SEASONAL) (FLUMIST QUADRIVALENT) | MEDIMMUNE VACCINES, INC. | 1 | WF2585 | IN / NS |
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | TF27T | IM / LA |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | X026926 | IM / RA |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 2 | Y008284 | SC / LA |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 2 | Y008284 | OT / LA |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y008284 | — |
No additional AE; Improper storage of PROQUAD; This spontaneous report was received from a Registered Nurse and refers to a(n) 11-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant medications included Human Papillomavirus 9-valent Vaccine, Recombinant (Gardasil 9), Flumist (Influenza vaccine live reassort 3v), Havrix (Hepatitis a vaccine inact) . On 21-Nov-2024, the patient started therapy with an improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (lot #Y008284, expiration date: 21-Oct-2025), dose number 2, administered by Subcutaneous route in Left Arm for prophylaxis (dose not reported) (improper storage of product in use). No adverse event was reported.; Sender's Comments: Priority : 5 , Is case serious : No , Index user :, Index date : 2025-02-26 , MNSC number : , CLIC number : , ESTAR number : , IRMS number : 03/01/2013 , Central date : 2025-02-20 , Classification : DMC, Attachment description : Post Marketing Basic , Safety case number :
Gardasil 9; Gardasil 9; Flumist; Havrix